Response to “Neonatal form of biotin-thiamine-responsive basal ganglia disease. Clues to diagnosis”

References (13)

1. Değerliyurt A, Gündüz M, Ceylaner S, Ünal Ö, Ünal S. Neonatal form of biotin-thiamine-responsive basal ganglia disease. Clues to diagnosis. Turk J Pediatr 2019
2. Tabarki B, Al-Hashem A, Alfadhel M. Biotin-thiamine-responsive basal ganglia disease. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, (eds). GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle
3. Algahtani H, Ghamdi S, Shirah B, Alharbi B, Algahtani R, Bazaid A. Biotin-thiamine-responsive basal ganglia disease: catastrophic consequences of delay in diagnosis and treatment. Neurol Res 2017
4. Savasta S, Bassanese F, Buschini C, et al. Biotin-thiamine responsive encephalopathy: report of an Egyptian family with a novel SLC19A3 mutation and review of the literature. J Pediatr Genet 2019
5. Kamaşak T, Havalı C, İnce H, et al. Are diagnostic magnetic resonance patterns life-saving in children with biotin-thiamine-responsive basal ganglia disease? Eur J Paediatr Neurol 2018
6. van der Knaap MS, Kevelam SH. Reply: infantile leigh-like syndrome caused by SLC19A3 mutations is a treatable disease. Brain 2014
7. 137(Pt 9): e296. 7.Flønes I, Sztromwasser P, Haugarvoll K, et al. Novel SLC19A3 promoter deletion and allelic silencing in biotin-thiamine-responsive basal ganglia encephalopathy. PLoS One 2016
8. e0149055. 8.Tabarki B, Alfadhel M, AlShahwan S, Hundallah K, AlShafi S, AlHashem A. Treatment of biotin-responsive basal ganglia disease: open comparative study between the combination of biotin plus thiamine versus thiamine alone. Eur J Paediatr Neurol 2015
9. Ozand PT, Gascon GG, Al Essa M, et al. Biotin-responsive basal ganglia disease: a novel entity. Brain 1998
10. 121(Pt 7): 1267-1279. 10.Kassem H, Wafaie A, Alsuhibani S, Farid T. Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment. AJNR Am J Neuroradiol 2014
11. Alfadhel M, Almuntashri M, Jadah RH, et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases. Orphanet J Rare Dis 2013
12. Gerards M, Kamps R, van Oevelen J, et al. Exome sequencing reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-childhood fatal Leigh syndrome. Brain 2013
13. 136(Pt 3): 882-890. 13.Ortigoza-Escobar JD, Serrano M, M